Impact of CDK4/6 Inhibitors on Aromatase Inhibitor-Associated Musculoskeletal Syndrome (AIMSS) in the Adjuvant Setting

• Główni autorzy: Efthymia Skafida (Autor), Angeliki Andrikopoulou (Autor), Evangelos Terpos (Autor), Christos Markellos (Autor), Savvina Moustafa (Autor), Dimitrios Pectasides (Autor), Meletios-Athanasios Dimopoulos (Autor), Flora Zagouri (Autor), Dimitrios Vassilopoulos (Autor)
• Format: Książka
• Wydane: Hindawi-Wiley, 2023-01-01T00:00:00Z.
• Hasła przedmiotowe: article
• Dostęp online: Connect to this object online.

Background. Third-generation aromatase inhibitors (AIs) are the mainstay of treatment in hormone receptor (HR)-positive breast cancer. Even though it is considered to be a well-tolerated therapy, AI-induced musculoskeletal symptoms are common and may be accused for treatment discontinuation. Recentl...